Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Autori principali: Rory Barry (Autore), Gregg Murray (Autore), Sally McGrath (Autore), Clive Kilgallen (Autore), Karen Eustace (Autore)
• Natura: Libro
• Pubblicazione: Wiley, 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...